A vacation bench of the Bombay High Court has granted a permanent injunction restraining Jackson Laboratories Pvt Ltd from manufacturing or selling their trademark Spasmo-pronyvon or any other drug that is deceptively similar to Wockhardt Limited’s pain relief drug, Spasmoproxyvon.
Justice SJ Kathawalla was hearing a notice of motion in a suit filed by Wockhardt Limited against Jackson Laboratories. He decreed the suit in terms of prayer clauses seeking a permanent injunction against the respondents from selling, manufacturing, marketing, advertising of any trademark that is deceptively similar to Wockhardt’s registered trademark Spasmoproxyvon.
The plaintiffs also prayed that-
Wockhardt Limited also sought the destruction of any such stock of drug named Spasmo-pronyvon which was also allowed by the court.
Apart from this, the defendants (Jackson Labs) agreed to pay Rs.6 lakh towards damages within a period of two days from the date of the order.
While Advocate Rohan Cama appeared for the plaintiff, Advocate Sagar Ghogre appeared for defendants Jackson Labs.